Kronos Bio Inc (NASDAQ:KRON) shares, rose in value on Wednesday, June 18, with the stock price down by -2.02% to the previous day’s close as strong demand from buyers drove the stock to $0.87.
Actively observing the price movement in the last trading, the stock closed the session at $0.88. Referring to stock’s 52-week performance, its high was $1.60, and the low was $0.65. On the whole, KRON has fluctuated by 28.84% over the past month.
With the market capitalization of Kronos Bio Inc currently standing at about $52.87 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2024-Nov-13.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that KRON’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of KRON currently trading nearly 11.44% and 10.73% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 63.86, while the 7-day volatility ratio is showing 1.42% which for the 30-day chart, stands at 5.84%. Furthermore, Kronos Bio Inc (KRON)’s beta value is 1.64, and its average true range (ATR) is 0.04.
A comparison of Kronos Bio Inc (KRON) with its peers suggests the former has fared considerably weaker in the market. KRON showed an intraday change of -2.02% in last session, and over the past year, it shrunk by -19.71%%.
Data on historical trading for Kronos Bio Inc (NASDAQ:KRON) indicates that the trading volumes over the past 3 months, they’ve averaged 787.09K. According to company’s latest data on outstanding shares, there are 60.97 million shares outstanding.
Nearly 35.30% of Kronos Bio Inc’s shares belong to company insiders and institutional investors own 22.98% of the company’s shares. The stock has fallen by -8.73% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the KRON stock heading into the next quarter.
